HPV vaccine may be cost-effective strategy for preventing oropharyngeal cancer in males
the ONA take:
According to a new study published online early in the journal Cancer, researchers from Princess Margaret Cancer Centre in Toronto, Ontario, Canada, have found that vaccinating adolescent boys against the human papillomavirus (HPV) may be a cost-effective approach for preventing squamous cell oropharyngeal cancer.
For the study, researchers applied a statistical model to a population of over 190,000 Canadian boys who were 12 years old in 2012. Results showed that the HPV vaccination could save $8 million to $28 million Canadian dollars over the boys' lifetimes.
The findings of this study are important because HPV-related oropharygneal cancer is projected to become the most common HPV-related cancer in the United States by 2020.
The authors of the study hope that the findings of this study will increase public awareness and persuade policymakers across the world to fund the HPV vaccination in boys.
HPV vaccinations, such as Gardasil, are known to be effective at reducing the risk of cervical, vulvar, vaginal, and anal cancer in females, and anal cancer in males.
HPV vaccine may be a cost-effective approach for preventing squamous cell oropharyngeal cancer.
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Colorectal Cancer Rates Increased Sharply Among Generation X and Millennials
- Pneumonia Associated With Common Cold May Cause Fatal Illness in Stem Cell Transplant Recipients
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Antiperspirants/Deodorants and Breast Cancer (Fact Sheet)
- Genome Sequencing Explains Resistance to CTLA-4 and PD-1 Inhibitors in Metastatic Melanoma
- Lifestyle Choices Have Greater Influence on Colon and Rectal Cancer Risk
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Nasal Biomarker in Smokers Could Predict Lung Cancer
- Arm Lymphoscintigraphy After Axillary Lymph Node Dissection or Sentinel Lymph Node Biopsy in Breast Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|